Suvoda Announces 30% Growth in 2023 Driven by Strong Customer Adoption of New Suvoda Platform and Products

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Suvoda-LLC

More Like This

PR Newswire associated0

Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient

PR Newswire associated0

Suvoda eCOA Earns High Marks in Patient Usability Study

PR Newswire associated0

Suvoda Awarded US Patent for its eCOA Software Architecture

PR Newswire associated0

Suvoda launches Sofia, a new AI assistant to simplify management of clinical trials

PR Newswire associated0

Suvoda Introduces Advanced Drug Optimization For IRT to Improve Accuracy of Clinical Trial Drug Supply Management

PR Newswire associated0

Suvoda Expands Clinical Trial Patient Travel Access Across the EU With Bolt Business Partnership

Business Wire logo

Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency

SODA V, AI-Driven Tool, Set to Disrupt the Auto Market and Cut Car Development Time and Costs by 90%